Results 101 to 110 of about 3,642 (160)

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. [PDF]

open access: yesJ Clin Oncol, 2016
Schmidt MK   +83 more
europepmc   +1 more source

Practical implementation of frailty models in Mendelian risk prediction. [PDF]

open access: yesGenet Epidemiol, 2020
Huang T   +4 more
europepmc   +1 more source

Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. [PDF]

open access: yesNat Genet, 2012
Orr N   +44 more
europepmc   +1 more source

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. [PDF]

open access: yesBr J Cancer, 2012
Kämpjärvi K   +18 more
europepmc   +1 more source

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium. [PDF]

open access: yesBreast Cancer Res, 2016
Muranen TA   +43 more
europepmc   +1 more source

An association study between CHEK2 gene mutations and susceptibility to breast cancer. [PDF]

open access: yesComp Clin Path, 2017
Jalilvand M   +6 more
europepmc   +1 more source

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications. [PDF]

open access: yesBreast Cancer Res, 2011
Muranen TA   +9 more
europepmc   +1 more source

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. [PDF]

open access: yesJ Clin Oncol, 2012
Weischer M   +68 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy